Qiagen N.V.
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample mater…
Medical - Diagnostics & Research
NL, Venlo [HQ]
FA
Fundamental Analysis · Most Recent Quarter
A dedicated fundamental analysis might help you to get a quick overview
of the
financial stability. It is important to understand the
FA Algorithm
and the criterias before valuing it as a top-tier resource.
1
Financial Health
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Current Ratio | -7.31 | 1.84 | 1.99 | |
| Debt/Assets | n.A. | n.A. | n.A. | |
| Debt/Equity | n.A. | n.A. | n.A. | |
| Net Debt/EBITDA | 27.98 | 6.49 | 5.07 | |
| Naive Interpretation | member | |||
2
Per Share
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Book Value | -5.66 | 16.23 | 17.20 | |
| Cash | -15.73 | 4.03 | 4.78 | |
| Capex | 26.69 | -0.17 | -0.24 | |
| Free Cash Flow | -4.66 | 0.43 | 0.45 | |
| Revenue | -10.07 | 2.07 | 2.30 | |
| Naive Interpretation | member | |||
3
Profitability
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Gross Margin | -7.31 | 0.63 | 0.68 | |
| Operating Margin | -18.93 | 0.21 | 0.26 | |
| ROA | -13.00 | 0.01 | 0.02 | |
| ROE | -12.62 | 0.02 | 0.03 | |
| ROIC | -26.62 | 0.02 | 0.02 | |
| Naive Interpretation | member | |||
4
Valuation
The "Valuation Entry" for the Focus of QGEN is permitted for members.
5
Growth
The "Growth Entry" for the Focus of QGEN is permitted for members.
6
Leverage & Liquidity